| Filed On | Filing |
|---|---|
| 16 Nov 2026 |
Form 4: Carlet Michael, Executive VP, CFO
Bought 10,288 shares ($99.9K) · Received 6,469 shares by exercise or conversion · Gave up 1,874 shares to cover exercise price or tax ($18K) |
| 16 Nov 2026 |
Form 4: Kaufmann Michael C, Director
Bought 10,500 shares |
| 16 Nov 2026 |
Form 4: Cardazzi Marco, Executive VP and CMO
Bought 2,508 shares ($25.1K) |
| 16 Nov 2026 |
Form 4: Lane Jeannine J, Exec. VP, GC, Corp. Sec. & CCO
Bought 5,241 shares ($50.1K) |
| 16 Nov 2026 |
Form 4: Aarnes Robert B, Director
Bought 10,073 shares ($100K) |
| 13 Nov 2026 | SCHEDULE 13G |
| 12 Nov 2026 | 10-Q |
| 12 Nov 2026 |
8-K: Results of Operations and Financial Condition
1 The Company defines Adjusted Standalone EBITDA as Adjusted EBITDA less estimated recurring and ongoing costs |
| 05 Nov 2026 | SCHEDULE 13G/A |
| 30 Oct 2026 | SCHEDULE 13G |
| 30 Oct 2026 | SCHEDULE 13G |
| 13 Oct 2026 | 144 |
| 08 Oct 2026 | SCHEDULE 13G |
| 05 Oct 2026 |
Form 4: Walker Brian Charles, Director
Granted 930 Deferred Restricted Stock Units ($16.4K) |
| 05 Oct 2026 |
Form 4: Galvin William, Director
Granted 907 Deferred Restricted Stock Units ($16K) |
| 05 Oct 2026 |
Form 4: Hostetler Cynthia Lynn, Director
Granted 1,044 Deferred Restricted Stock Units ($18.4K) |
| 01 Oct 2026 | 144 |
| 11 Sep 2026 | 144 |
| 08 Sep 2026 | SCHEDULE 13G |
| 04 Sep 2026 | SCHEDULE 13G |
Loading...